BR0110383A - Peptìdeo modulador de receptor de trombopoietina - Google Patents

Peptìdeo modulador de receptor de trombopoietina

Info

Publication number
BR0110383A
BR0110383A BR0110383-0A BR0110383A BR0110383A BR 0110383 A BR0110383 A BR 0110383A BR 0110383 A BR0110383 A BR 0110383A BR 0110383 A BR0110383 A BR 0110383A
Authority
BR
Brazil
Prior art keywords
receptor modulator
thrombopoietin receptor
modulator peptide
peptide
thrombopoietin
Prior art date
Application number
BR0110383-0A
Other languages
English (en)
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of BR0110383A publication Critical patent/BR0110383A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"PEPTìDEO MODULADOR DE RECEPTOR DE TROMBOPOIETINA". A presente invenção se refere a novas composições farmacêuticas e para diagnóstico que permitem o tratamento de trombocitopenia.
BR0110383-0A 2000-04-25 2001-04-23 Peptìdeo modulador de receptor de trombopoietina BR0110383A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number Publication Date
BR0110383A true BR0110383A (pt) 2003-01-21

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110383-0A BR0110383A (pt) 2000-04-25 2001-04-23 Peptìdeo modulador de receptor de trombopoietina

Country Status (24)

Country Link
US (1) US20030181659A1 (pt)
EP (2) EP1149906A1 (pt)
JP (1) JP2003530867A (pt)
KR (1) KR20030009450A (pt)
CN (1) CN1426467A (pt)
AR (1) AR030278A1 (pt)
AU (2) AU2001267366B9 (pt)
BG (1) BG107214A (pt)
BR (1) BR0110383A (pt)
CA (1) CA2407167A1 (pt)
CZ (1) CZ20023517A3 (pt)
EA (1) EA006423B1 (pt)
EE (1) EE200200610A (pt)
GE (1) GEP20063763B (pt)
HU (1) HUP0300559A3 (pt)
IL (1) IL152204A0 (pt)
IS (1) IS6582A (pt)
MX (1) MXPA02010458A (pt)
NO (1) NO20025114L (pt)
PL (1) PL358304A1 (pt)
SK (1) SK15262002A3 (pt)
WO (1) WO2001080873A2 (pt)
YU (1) YU79202A (pt)
ZA (1) ZA200208662B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1451364A4 (en) * 2001-11-07 2007-08-22 Millennium Pharm Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS USING GENES 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 OR 58874
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
MXPA05003057A (es) * 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
CA2509914A1 (en) 2002-12-11 2004-06-24 Ferrosan A/S Gelatine-based materials as swabs
WO2004101600A2 (en) * 2003-05-12 2004-11-25 Affymax, Inc. Novel poly(ethylene glycol) modified compounds and uses thereof
MXPA05012314A (es) * 2003-05-12 2006-04-18 Affymax Inc Radical separador para peptido modificado con polietilenglicol.
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
WO2005072700A2 (en) 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
CN101001649B (zh) 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
AU2007210643B2 (en) * 2006-01-31 2013-09-19 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Method for determination of condition of disseminated intravascular coagulation syndrome
CA2716872C (en) 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
JP5824760B2 (ja) * 2011-05-13 2015-12-02 国立大学法人 東京大学 多核化巨核球細胞、及び血小板の製造方法
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
RU2700162C2 (ru) 2013-06-21 2019-09-13 Ферросан Медикал Дивайсиз А/С Расширенная под вакуумом сухая композиция и шприц для ее сохранения
EP3470094B1 (en) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2019215274A1 (en) 2018-05-09 2019-11-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
AU6046696A (en) * 1995-06-07 1996-12-30 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
CA2322200A1 (en) * 1998-02-24 1999-08-26 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
IS6582A (is) 2002-10-14
IL152204A0 (en) 2003-05-29
YU79202A (sh) 2006-01-16
GEP20063763B (en) 2006-03-10
CA2407167A1 (en) 2001-11-01
US20030181659A1 (en) 2003-09-25
KR20030009450A (ko) 2003-01-29
WO2001080873A3 (en) 2002-01-31
EA006423B1 (ru) 2005-12-29
HUP0300559A2 (hu) 2003-06-28
HUP0300559A3 (en) 2005-09-28
AU6736601A (en) 2001-11-07
BG107214A (bg) 2003-11-28
ZA200208662B (en) 2003-10-27
AR030278A1 (es) 2003-08-20
EP1278849A2 (en) 2003-01-29
NO20025114L (no) 2002-12-18
MXPA02010458A (es) 2003-06-06
AU2001267366B9 (en) 2005-07-14
AU2001267366B2 (en) 2005-06-30
SK15262002A3 (sk) 2003-05-02
EP1149906A1 (en) 2001-10-31
CZ20023517A3 (cs) 2003-10-15
EA200201138A1 (ru) 2003-06-26
EE200200610A (et) 2004-08-16
CN1426467A (zh) 2003-06-25
JP2003530867A (ja) 2003-10-21
WO2001080873A2 (en) 2001-11-01
PL358304A1 (en) 2004-08-09
NO20025114D0 (no) 2002-10-24

Similar Documents

Publication Publication Date Title
BR0110383A (pt) Peptìdeo modulador de receptor de trombopoietina
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BR0213477A (pt) Grânulos orais e composição farmacêutica escoável e dispersìvel
BR0210503A (pt) Ligandos para receptor de 5-ht e suas utilizações
BR0011448A (pt) Imidazoquinolinas substituìdas por amida
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
BR0307998A (pt) Hidroxietilaminas substituìdas
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
BR0016022A (pt) Vacina para a prevenção e tratamento da doença de alzheimer e doenças relacionadas ao amilóide
PT1235799E (pt) Forma polimorfica de atorvastatina-calcio
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
BR0210481A (pt) Tablete de caldo de carne compacto
BR0206362A (pt) Produto para tratamento de lentes de contato contendo dexpantenol
BR0114912A (pt) Kahalalide f
BR0117123A (pt) Dispositivo de retenção gástrica expansìvel
BR0210543A (pt) Tablete macio de caldo de carne
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
MY133512A (en) Non-steroidal il-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors
BR0209290A (pt) Tratamento de demência e doenças neurodegenerativas com doses intermediárias de antagonistas de lhrh
BRPI0412740A (pt) formulações auto-emulsifcantes e automicroemulsificantes para a administração oral de taxóides
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
TNSN02038A1 (fr) Composes conjugues de pregabaline et de lactose nouveaux, et compositions les contenant

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2008 DE 30/06/2009.